This topic contains a solution. Click here to go to the answer

Author Question: _________ of TANF families has non-TANF income. a. 50 b. 40 c. 25 d. ... (Read 69 times)

formula1

  • Hero Member
  • *****
  • Posts: 666
_________ of TANF families has non-TANF income.
 
  a. 50
  b. 40
  c. 25
  d. 0

Question 2

Which of the following conditions can be systemic barriers to obtaining counseling services for underserved populations?
 
  a. scheduling individual sessions with children
  b. strict adherence to 50-minute sessions
  c. unavailability of affordable or reliable transportation
  d. all of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

AaaA

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

C

Answer to Question 2

d




formula1

  • Member
  • Posts: 666
Reply 2 on: Jul 31, 2018
Great answer, keep it coming :)


okolip

  • Member
  • Posts: 362
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library